US Bancorp
PASG icon

US Bancorp’s Passage Bio PASG Stock Holding History

US Bancorp’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-25
Closed -$329 – 4101
2023
Q3 		$329 Hold
25
– – ﹤0.01% 3888
2023
Q2 		$471 Hold
25
– – ﹤0.01% 3876
2023
Q1 		$479 Hold
25
– – ﹤0.01% 3951
2022
Q4 		$690 Hold
25
– – ﹤0.01% 3967
2022
Q3 		$1K Hold
25
– – ﹤0.01% 3992
2022
Q2 		$1K Hold
25
– – ﹤0.01% 3986
2022
Q1 		$2K Sell
25
-239
-91% -$19.7K ﹤0.01% 3852
2021
Q4 		$34K Buy
264
+239
+956% +$39K ﹤0.01% 2844
2021
Q3 		$5K Hold
25
– – ﹤0.01% 3653
2021
Q2 		$7K Buy
+25
New +$7.74K ﹤0.01% 3527
2020
Q4 		– Sell
-35
Closed -$9K – 3860
2020
Q3 		$9K Buy
+35
New +$12K ﹤0.01% 3122

Other funds holding PASG

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

US Bancorp's PASG Position: Q4 2023 in Review

US Bancorp sold out of Passage Bio (PASG) in Q4 2023, closing a stake of 25 shares — an estimated $329 sold.

US Bancorp first reported a position in PASG in Q3 2020 and held it in 11 quarters. The position peaked at $34K in Q4 2021. 50 funds tracked by Wall St. Rank hold PASG as of Q4 2023.

  • US Bancorp reported no remaining Passage Bio position as of Q4 2023 after selling out during the quarter.
  • US Bancorp sold 25 Passage Bio shares in Q4 2023, an estimated $329.
  • US Bancorp first reported a position in Passage Bio in Q3 2020 and held it in 11 quarters.
  • US Bancorp's Passage Bio position peaked at $34K in Q4 2021.
  • 50 funds tracked by Wall St. Rank held Passage Bio as of Q4 2023.

Based on US Bancorp's 13F filing for Q4 2023, filed 9 Feb 2024.